Cabaletta Bio, Inc.
CABA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $239,295 | $94,052 | $68,838 | $113,800 |
| - Cash | $60,206 | $145,612 | $131,830 | $163,962 |
| + Debt | $25,780 | $24,893 | $28,793 | $15,600 |
| Enterprise Value | $204,869 | -$26,667 | -$34,199 | -$34,562 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$345 | -$468 | -$485 | -$468 |
| % Margin | – | – | – | – |
| EBITDA | -$43,937 | -$44,089 | -$35,164 | -$31,370 |
| % Margin | – | – | – | – |
| Net Income | -$44,866 | -$45,128 | -$35,943 | -$32,586 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.44 | -0.73 | -0.73 | -0.65 |
| % Growth | 39.7% | 0% | -12.3% | – |
| Operating Cash Flow | -$34,509 | -$30,426 | -$30,802 | -$23,122 |
| Capital Expenditures | -$78 | -$161 | -$785 | -$376 |
| Free Cash Flow | -$34,587 | -$30,587 | -$31,587 | -$23,498 |